Results 111 to 120 of about 601,648 (321)

Mental health problems: Are they or are they not a risk factor for dropout from drug treatment? A systematic review of the evidence [PDF]

, 2009
Background: A sizeable number of recent studies investigating whether clients with substance misuse and mental health problems (dual diagnosis clients) are at heightened risk of dropout from drug treatment have been published.
Broome KM, Christine Barrowclough, Crawford V, Goldstein MF, Gossop M, Gossop M, Lewin TJ, Martinez-Raga J, Petra S. Meier, Ross HE, Schulte S   +10 more
core   +1 more source

Predictors of Frequent Emergency Department Use and Hospitalization among Patients with Substance-Related Disorders Recruited in Addiction Treatment Centers. [PDF]

Int J Environ Res Public Health, 2022
Fleury MJ, Cao Z, Grenier G, Huỳnh C.
europepmc   +1 more source

Exercise-related activities are associated with positive outcome in contingency management treatment for substance use disorders [PDF]

, 2008
Jeremiah Weinstock, Danielle Barry, Nancy M. Petry   +2 more
openalex   +1 more source

The impact of frailty syndrome on skeletal muscle histology: preventive effects of exercise

FEBS Open Bio, EarlyView.
Frailty syndrome exacerbates skeletal muscle degeneration via increased ECM deposition and myofiber loss. This study, using a murine model, demonstrates that endurance exercise attenuates these histopathological alterations, preserving muscle integrity. Findings support exercise as a viable strategy to counteract frailty‐induced musculoskeletal decline
Fujue Ji, Hae Sung Lee, Haesung Lee, Jong‐Hee Kim   +3 more
wiley   +1 more source

Substance use and depression. Comparative course in adolescents [PDF]

, 2018
Objective: To examine the relation between depression and substance use in adolescents and the concomitant courses of both disorders. Methods: Four individual interviews were administered to 85 adolescent substance users aged 14-19 years (mean 17.1 years,
Bernard, Mathieu, Bolognini, Monique, Chinet, Léonie, Daniele, Giusi, Halfon, Olivier, Laget, Jacques, Plancherel, Bernard   +6 more
core  

Pathways to substance-related disorder: a structural model approach exploring the influence of temperament, character, and childhood adversity in a national cohort of prisoners [PDF]

, 2008
M. Lukasiewicz, Xavier Neveu, Lisa Blecha, Bruno Falissard, Michel Reynaud, I. Gasquet   +5 more
openalex   +1 more source

FEM1B enhances TRAIL‐induced apoptosis in T lymphocytes and monocytes

FEBS Open Bio, EarlyView.
FEM1B facilitates TRAIL‐induced apoptosis through distinct mechanisms in T lymphocytes and monocytes. In T lymphocytes, FEM1B engages with TRAF2, leading to a reduction in TRAF2 expression, which subsequently lessens TRAF2's inhibitory influence on caspase‐8.
Chenbo Yang, Wenhui Yu, Cui Dang, Jingjing Zhang, Jiahan Lu, Jing Xue   +5 more
wiley   +1 more source

Bibliometric Insights in Genetic Factors of Substance-Related Disorders: Intellectual Developments, Turning Points, and Emerging Trends. [PDF]

Front Psychiatry, 2021
Wang K, Duan Y, Duan W, Yu Y, Zheng N, Hu J, He J, Chen H, Liang M.   +8 more
europepmc   +1 more source

Substance use disorders among inhalant users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions [PDF]

, 2008
Li‐Tzy Wu, Matthew O. Howard, Daniel J. Pilowsky   +2 more
openalex   +1 more source

GDP‐fucose transporter SLC35C1: a potential regulatory role in cytosolic GDP‐fucose and fucosylated glycan synthesis

FEBS Open Bio, EarlyView.
The inactivation of SLC35C1 (GDP‐fucose transporter) and enzymes involved in GDP‐fucose biosynthesis was studied. Fucose supplementation increases the level of GDP‐fucose to abnormal, millimolar values in the absence of the TSTA3 protein and SLC35C1 in contrast to the GMDS/SLC35C1 double mutant.
Edyta Skurska, Mariusz Olczak
wiley   +1 more source